Efficacy, Safety and Tolerability of Rivastigmine Patch in Patients With Mild to Moderate Alzheimer's Disease Switched From Cholinesterase Inhibitors (\)
This study is currently recruiting participants.
Verified May 2013 by Novartis
Study NCT01529619
Information provided by Novartis
First Received on February 6, 2012.
Last Updated on May 8, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
